Tempus AI (TEM) Stock Climbs After First Quarterly Profit and AI Cancer Breakthrough

Tempus AI (TEM) stock surged over 11% to $50.95 after reporting its first quarterly profit and an AI cancer breakthrough published in Nature Medicine. The PRISM2 AI model was highlighted as a top cancer detection tool. A short squeeze may be contributing, with over 30% of the float sold short.